Soaring cancer-drug costs cause problems for physicians

Hyperexpensive cancer drugs are putting pressure on U.S. oncologists, who have to deal with increasing delays and denials of reimbursement, as well as payment conflicts with drug distributors. Doctors say the trend has influenced their treatment decisions, prompting some to prescribe cheaper alternatives to help patients avoid pricey medicines. As a result, the median income of oncologists in 2006 and 2007 was roughly flat after nearly 10 years of increasing salaries, according to the Medical Group Management Association.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ